Amid US Decoupling, China Faces EU Pressure On Biosecurity Law
'In China For China' Meets New Reality
After proposing a sweeping biosecurity law in May, China is facing pressure from European governments for potentially posing severe restrictions on key sectors such as life sciences and biological research.
You may also be interested in...
From requiring early notification to whole-process involvement, China is clearing a path for a far-reaching new biosecurity law, which if implemented will pose high hurdles for international firms planning to conduct clinical studies in the country, industry observers say.
As the China immuno-oncology sector becomes increasingly crowded, CStone teams up with an innovative US business partner to go global.
During a recent press briefing, health officials in China disclosed the country is poised to reach an annual production capacity of 610 million doses for coronavirus vaccines. But they said prices must be based on manufacturing costs and not driven by supply and demand.